165 related articles for article (PubMed ID: 3402470)
1. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470
[TBL] [Abstract][Full Text] [Related]
2. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
[TBL] [Abstract][Full Text] [Related]
3. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Stohler R; Keller U; Riesen WF
Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
[TBL] [Abstract][Full Text] [Related]
6. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia.
Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V
Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582
[TBL] [Abstract][Full Text] [Related]
8. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
[TBL] [Abstract][Full Text] [Related]
9. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.
Di Paolo B; Del Rosso G; Catucci G; Vocino V; Terenzio MG; Bonomini M; Suriani K; Albertazzi A
ASAIO Trans; 1990; 36(3):M578-80. PubMed ID: 2252755
[TBL] [Abstract][Full Text] [Related]
11. Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation.
Barbir M; Rose M; Kushwaha S; Akl S; Mitchell A; Yacoub M
Int J Cardiol; 1991 Nov; 33(2):241-6. PubMed ID: 1743784
[TBL] [Abstract][Full Text] [Related]
12. Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment.
Neuman MP; Neuman HR; Neuman J
Atherosclerosis; 1991 Dec; 91 Suppl():S11-9. PubMed ID: 1789812
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
[TBL] [Abstract][Full Text] [Related]
14. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
[TBL] [Abstract][Full Text] [Related]
15. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia.
Twickler TB; Dallinga-Thie GM; de Valk HW; Schreuder PC; Jansen H; Cabezas MC; Erkelens DW
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2422-7. PubMed ID: 11073847
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.
Bard JM; Luc G; Douste-Blazy P; Drouin P; Ziegler O; Jacotot B; Dachet C; De Gennes JL; Fruchart JC
Eur J Clin Pharmacol; 1989; 37(6):545-50. PubMed ID: 2693115
[TBL] [Abstract][Full Text] [Related]
17. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
Feussner G; Eichinger M; Ziegler R
Clin Investig; 1992 Nov; 70(11):1027-35. PubMed ID: 1472833
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
Steinhagen-Thiessen E
Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
